Maternal vitamin D during pregnancy and offspring autism and autism-associated traits: a prospective cohort study

• Published in: Molecular autism 2022-11, Vol.13 (1), p.44-14, Article 44
• Main Authors: Madley-Dowd, Paul, Dardani, Christina, Wootton, Robyn E, Dack, Kyle, Palmer, Tom, Thurston, Rupert, Havdahl, Alexandra, Golding, Jean, Lawlor, Deborah, Rai, Dheeraj
• Format: Article
• Language: English
• Subjects: Alfacalcidol; ALSPAC; Autism; Autistic children; Autistic Disorder - epidemiology; Autistic Disorder - etiology; Bias; Calcifediol; Care and treatment; Child; Cohort analysis; Cohort Studies; Communication; Diagnosis; Female; Gestational age; Health aspects; Humans; Longitudinal Studies; Measurement; Mendelian randomization; Pregnancy; Pregnant women; Prospective Studies; Risk factors; Siblings; Vitamin D; Vitamin deficiency
• ISSN: 2040-2392; 2040-2392
• DOI: 10.1186/s13229-022-00523-4

There has been a growing interest in the association between maternal levels of vitamin D during pregnancy and offspring autism. However, whether any associations reflect causal effects is still inconclusive. We used data from a UK-based pregnancy cohort study (Avon Longitudinal Study of Parents and Children) comprising 7689 births between 1991 and 1992 with maternal blood vitamin D levels recorded during pregnancy and at least one recorded outcome measure, including autism diagnosis and autism-associated traits. The association between each outcome with seasonal and gestational age-adjusted maternal serum 25-hydroxyvitamin D during pregnancy was estimated using confounder-adjusted regression models. Multiple imputation was used to account for missing data, and restricted cubic splines were used to investigate nonlinear associations. Mendelian randomization was used to strengthen causal inference. No strong evidence of an association between maternal serum 25-hydroxyvitamin D during pregnancy and any offspring autism-associated outcome was found using multivariable regression analysis (autism diagnosis: adjusted OR = 0.98, 95% CI = 0.90-1.06), including with multiple imputation (autism diagnosis: adjusted OR = 0.99, 95% CI = 0.93-1.06), and no evidence of a causal effect was suggested by Mendelian randomization (autism diagnosis: causal OR = 1.08, 95% CI = 0.46-2.55). Some evidence of increased odds of autism-associated traits at lower levels of maternal serum 25-hydroxyvitamin D was found using spline analysis. Our study was potentially limited by low power, particularly for diagnosed autism cases as an outcome. The cohort may not have captured the extreme lows of the distribution of serum 25-hydroxyvitamin D, and our analyses may have been biased by residual confounding and missing data. The present study found no strong evidence of a causal link between maternal vitamin D levels in pregnancy and offspring diagnosis or traits of autism.